FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

316943005: Compound magnesium trisilicate 250 mg tablet (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2153191010 Compound magnesium trisilicate 250 mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2160824013 Compound magnesium trisilicate 250 mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    461617012 Compound magnesium trisilicate tablet BP en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    713993010 Compound magnesium trisilicate tablet BP (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1187927011 Compound magnesium trisilicate tablet BP (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2153191010 Compound magnesium trisilicate 250 mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2153191010 Compound magnesium trisilicate 250 mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2160824013 Compound magnesium trisilicate 250 mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2160824013 Compound magnesium trisilicate 250 mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Compound magnesium trisilicate 250 mg tablet Is a Magnesium trisilicate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Trace element supplementation false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium supplement false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium trisilicate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium-based antacid false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aluminium false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Magnesium false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Compound magnesium trisilicate 250 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start